April 4, 1987 |
After a year and a half of stalled growth, Time Inc.'s HBO and Cinemax pay-television services have been rapidly adding subscribers since late 1986, and seem likely to continue to do so, Time officials said Friday. Addressing financial analysts, Time President Nicholas J. Nicholas and Chief Executive J. Richard Munro said the two services gained 800,000 subscribers in 1986, and had continued their rapid growth in the first months of this year.
October 16, 1987 |
After two days of silence in the face of an unsolicited takeover bid, record and video retailer Wherehouse Entertainment on Thursday rejected out of hand a proposed meeting with Shamrock Holdings to discuss its $14.25-a-share bid. Louis A. Kwiker, president and chief executive of Torrance-based Wherehouse, said the board determined that "now is not the time to sell the company and that significantly higher value can be achieved by the company continuing to pursue its business plan."
July 15, 1985 |
Cancer was found in the two-inch tumor removed from President Reagan's colon last Saturday, his doctor said today. The doctor said there was no evidence that the malignancy had spread. Navy Capt. Dale Oller, who headed a six-person surgical team, quoted the President as saying of the malignant polyp, "I'm glad that's all out." Dr. Steven Rosenberg of the National Cancer Institute, another of Reagan's physicians, said simply, "The President has cancer."
January 20, 1989 |
The government gave scientists permission Thursday to transfer foreign genes into humans for the first time, approving a test in which bacteria genes will be used to track the effectiveness of a new cancer therapy. After seven months of review, Dr. James Wyngaarden, director of the National Institutes of Health, gave a team of government researchers the go-ahead to begin the gene-transfer trials. The Food and Drug Administration approved the plan earlier this week.
July 15, 1985 |
President Reagan and the world will know sometime today whether the two-inch-wide polyp removed from his colon on Saturday was benign or malignant, and if malignant, the likelihood that cancer cells may have spread to other organs. The 48-hour delay in learning the answer is necessitated by the meticulous and time-consuming procedure that pathologists use to get the most accurate answers possible.
June 5, 1986 |
Home Box Office, the nation's largest pay-television company, announced Wednesday that it has signed a five-year pact for the pay-TV rights of Warner Bros. motion pictures. Financial details were not disclosed, but industry analyst Steven Rosenberg estimated that the deal will cost HBO, a Time Inc. subsidiary, at least $300 million and possibly more than $600 million during the five-year period.
July 14, 1985 |
President Reagan's physicians said Saturday that his postoperative recovery from intestinal surgery is excellent, but his longer-term prognosis depends heavily on the outcome of the pathology report due Monday. That report, based on an extensive microscopic examination of tissue, will indicate whether cancer was present in the two-inch polyp removed from the President's colon Saturday during a 2-hour, 53-minute operation at Bethesda Naval Medical Center by a team of six doctors led by Capt.
September 20, 2002 |
Ten of the most desperate skin cancer patients have had their tumors stopped or nearly destroyed by a new treatment that involves replacing virtually their entire immune systems with specially targeted killer cells, researchers said Thursday. Although the treatment failed completely in three patients, those who responded had few side effects and several were able to go back to work or school, said the National Cancer Institute's Dr. Steven Rosenberg, who led the study.
December 22, 2001
UCLA-professor-turned-venture-capitalist Nir Kossovsky recently talked about how profits, once considered an almost shameful motive for academic research, have increasingly become its driving force. As he summed it up, "Faculty who drive Porsches are not necessarily embarrassed anymore.'
April 19, 1987 |
A decade ago, an independent producer with a $10-million project would almost certainly have tried to strike a theatrical-distribution deal with one of the major studios, and a group of executives hardly larger than a courtroom jury could have delivered a death sentence to his project. Today, he might decide to bypass the studios altogether and try to piece together his budget by selling domestic home video rights, foreign theatrical rights and cable-TV and syndication rights.